Korean companies in race for domestic vaccine market

Published: 2009-06-30 06:58:00

Updated: 2009-06-30 06:58:00

Green Cross Corporation and Ilyang Pharm plan to expand their presence in the 300 billion-won domestic vaccine market as demand for various vaccines has been on the gradual increase due to emergence of new influenzae.

Green Cross plans to produce 20 million doses of vaccine with 72 billion won...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK